SNMMI Submits Comments to CMS Regarding Beta Amyloid

August 2, 2013

On August 1, 2013, SNMMI submitted comments to CMS regarding the proposed decision memorandum for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease.  CMS had previously released their proposed decision on July 3. In the decision, CMS stated there is insufficient evidence that the scan will improve health outcomes for patients with dementia or other neurodegenerative diseases.